Viewing Study NCT05751668


Ignite Creation Date: 2025-12-24 @ 5:43 PM
Ignite Modification Date: 2026-05-15 @ 3:21 PM
Study NCT ID: NCT05751668
Status: RECRUITING
Last Update Posted: 2025-08-05
First Post: 2023-02-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II)
Sponsor: Alliance for Clinical Trials in Oncology
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anatomic Stage IV Breast Cancer AJCC v8 View
None Chemotherapy-Induced Peripheral Neuropathy View
None Metastatic Breast Carcinoma View
Keywords: